North America Stem Cell Manufacturing Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
 예측 기간 |
2021 –2028 |
 시장 규모(기준 연도) |
USD 11,076.78 Million |
 시장 규모(예측 연도) |
USD 23,505.08 Million |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
>북미 줄기세포 제조 시장, 제품별(줄기세포 계통, 기구, 소모품 및 키트), 응용 분야(연구 응용 분야, 임상 응용 분야, 세포 및 조직 은행 및 기타), 최종 사용자(생명공학 및 제약 회사, 연구소 및 학술 기관, 세포 은행 및 조직 은행, 병원 및 수술 센터 및 기타), 유통 채널(직접 판매 및 제3자 유통업체), 국가별(미국, 캐나다 및 멕시코) 산업 동향 및 2028년까지의 예측.
시장 분석 및 통찰력: 북미 줄기세포 제조 시장
북미 줄기세포 제조 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년부터 2028년까지의 예측 기간 동안 10.1%의 CAGR로 성장하고 있으며 2020년의 11,076.78백만 달러에서 2028년까지 23,505.08백만 달러에 도달할 것으로 분석합니다. 암과 줄기세포 이식의 유병률 증가, 줄기세포 이식을 위한 새로운 기술 발전의 성장은 예측 기간 동안 시장 수요를 촉진하는 주요 동인이 될 가능성이 높습니다.
줄기세포는 다양한 세포로 분화할 수 있는 신체의 원료입니다. 이는 특수 기능을 가진 다른 모든 세포가 생성되는 세포를 의미합니다. 줄기세포 치료는 배아줄기세포, 이종 및 자가 치료를 위한 성인줄기세포를 포함한 모든 유형의 인간 줄기세포를 사용하는 의학적 상태에 대한 치료로 정의됩니다 .
줄기세포 연구의 출현은 줄기세포와 그 유도체 의 치료적 잠재력을 밝혀냈습니다 . 줄기세포와 그 유도체의 성공적인 제조는 의료 분야에 긍정적인 영향을 미치고 있습니다. 이러한 줄기세포 제품은 손상된 조직과 장기의 기능을 회복하고 암, 혈액학적 장애, 유전적 장애 , 자가면역 및 염증성 질환을 치료하기 위한 줄기세포 기반 세포 치료법을 개발하는 데 사용됩니다 .
혁신적 제품 개발을 위한 주요 산업 참여자들의 연구 개발 증가 , 정부의 지원, 줄기세포 채택 증가가 시장 성장을 견인하고 있습니다. 이 분야에 존재하는 진보된 방법론도 글로벌 줄기세포 제조 시장의 성장을 촉진하고 있습니다. 그러나 높은 치료 비용, 종양 치료 대안의 가용성이 시장을 제한할 수 있습니다. 시장 참여자들이 취한 전략적 이니셔티브와 함께 많은 수의 파이프라인 제품이 존재하여 시장에 기회가 되고 있습니다. 숙련된 전문가의 부족은 시장에 도전이 될 수 있습니다.
글로벌 줄기세포 제조 시장 보고서는 시장 점유율, 새로운 개발 및 국내 및 지역 시장 참여자의 영향에 대한 세부 정보를 제공하고, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서 기회를 분석합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 당사에 문의하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다.
줄기세포 제조 시장 범위 및 시장 규모
줄기세포 제조 시장은 제품, 응용 프로그램, 최종 사용자 및 유통 채널을 기반으로 하는 네 가지 주요 세그먼트로 분류됩니다. 세그먼트 간의 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 응용 분야와 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.
- 줄기세포 제조 시장은 제품을 기준으로 줄기세포 계통, 기구, 소모품 및 키트로 세분화됩니다. 2021년에는 소모품 구매가 잦고 줄기세포 연구가 증가하고 줄기세포 치료법에 대한 수요가 증가함에 따라 소모품 및 키트 부문이 시장을 지배할 것으로 예상됩니다.
- 세포 제조 시장은 응용 분야 기준으로 연구 응용 분야, 임상 응용 분야, 세포 및 조직 뱅킹 및 기타로 세분화됩니다. 2021년에는 줄기 세포 세포학 및 병리 생리학 연구에 대한 관심이 높아지고 줄기 세포 제품 개발 및 상용화를 지원하기 위한 공공-민간 자금이 증가함에 따라 연구 응용 분야 부문이 시장을 지배할 것으로 예상됩니다.
- 최종 사용자를 기준으로 줄기세포 제조 시장은 생명공학 및 제약 회사, 연구 기관 및 학술 기관, 세포 은행 및 조직 은행, 병원 및 수술 센터 등으로 세분화됩니다. 2021년에는 제약 및 생명공학 회사 부문이 줄기세포 연구 역량을 확장하기 위해 제약 및 생명공학 회사가 전략적 이니셔티브(인수, 파트너십 및 협업 등)에 중점을 두면서 시장을 지배할 것으로 예상됩니다.
- 유통 채널을 기준으로 줄기세포 제조 시장은 직접 판매와 제3자 유통업체로 세분화됩니다. 2021년에는 시장에 많은 플레이어가 있기 때문에 직접 판매 부문이 시장을 지배할 것으로 예상됩니다.
북미 줄기세포 제조 시장 국가 수준 분석
줄기세포 제조 시장을 분석하고, 제품, 응용 분야, 최종 사용자 및 유통 채널별로 시장 규모 정보를 제공합니다.
북미 줄기세포 제조 시장 보고서에서 다루는 국가는 미국, 캐나다, 멕시코입니다.
미국은 높은 GDP를 가진 가장 큰 소비자 시장, 만성 질환의 증가, 시장에 진출한 많은 수의 업체 덕분에 북미 지역에서 글로벌 줄기세포 제조를 주도하고 있습니다.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
The Growing Adoption of Stem Cell Therapy along with Public-Private Funding are Creating Opportunities in the Stem Cell Manufacturing Market
The stem cell manufacturing market also provides you with detailed market analysis for every country growth in particular industry with wound debridement device sales, impact of advancement in the ELISpot and FluorSpot assayand changes in regulatory scenarios with their support for the ELISpot and FluorSpot assay market. The data is available for historic period 2019 to 2020.
Competitive Landscape and North America Stem Cell Manufacturing Market Share Analysis
North America stem cell manufacturing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the stem cell manufacturing market.
The major companies providing the stem cell manufacturing are Thermo Fisher Scientific Inc., Merck KGaA, BD, Organogenesis Inc., Vericel Corporation, ANTEROGEN. CO., LTD., VistaGen Therapeutics, Inc., FUJIFILM Cellular Dynamics, Inc., American CryoSystem Corporation, PromoCell GmbH, Sartorius AG, ViaCyte, Inc., STEM CELL Technologies, Inc., Takeda Pharmaceutical Company Limited, DAIICHI SANKYO COMPANY, LIMITED, Bio-Techne, REPROCELL Inc., Catalent, Inc, Mesoblast Ltd, Astellas Pharma Inc. among others.
The strategic initiatives by market players along with new technological advancements for stem cell manufacturing is bridging the gap for various treatments.
For instance,
- In June 2021, REPROCELL Inc. announced that it has opened new seed iPSC manufacture suite to meet the increasing demand of Ipsc-derived master cell banks. This will help the company to address the rising demand and to grow in coming years.
- 2021년 6월, Catalent Inc.는 인간 유도 다능성 줄기 세포 제조업체인 RheinCell Therapeuics를 인수했다고 발표했습니다. 이를 통해 회사는 기존 맞춤형 세포 치료 프로세스 개발을 구축하는 데 도움이 될 것입니다.
- 2021년 6월, Bio-Techne은 유전자 공학 및 세포 및 유전자 치료 제조 역량을 강화했다고 발표했습니다. 이를 통해 회사는 사업을 더욱 확장할 수 있을 것입니다.
협력, 합작투자 및 기타 시장 참여자의 전략은 줄기세포 제조 시장에서 기업의 시장을 확대하고 있으며, 이를 통해 기업은 줄기세포 제조 시장에 대한 제공 서비스를 개선하는 데에도 도움이 됩니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA STEM CELL MANUFACTURING MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 NORTH AMERICA STEM CELL MANUFACTURING MARKET: REGULATIONS
5.1 REGULATORY FRAMEWORK IN THE UNITED STATES
5.2 REGULATORY FRAMEWORK IN EUROPE
5.3 REGULATORY FRAMEWORK IN INDIA
5.4 REGULATORY FRAMEWORK IN JAPAN
6 PESTEL ANALYSIS
7 PORTERS FIVE FORCES
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 INCREASING PREVALENCE OF CANCER
8.1.2 INCREASE INVESTMENT IN R & D
8.1.3 INCREASING ADOPTION OF STEM CELL THERAPY
8.1.4 GROWING BIOTECHNOLOGY SECTOR, ALONG WITH RISING HEALTHCARE EXPENDITURE
8.2 RESTRAINTS
8.2.1 HIGH COST ASSOCIATED WITH THERAPIES
8.2.2 AVAILABILITY OF ALTERNATIVES FOR TUMOR TREATMENT
8.2.3 ADVERSE EFFECTS OF STEM CELL TRANSPLANT
8.3 OPPORTUNITIES
8.3.1 PRESENCE OF PIPELINE PRODUCTS
8.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
8.3.3 RISING HEALTHCARE INFRASTRUCTURE BY VARIOUS COUNTRIES
8.3.4 INCREASING INTEREST FOR PERSONALIZED MEDICINE
8.4 CHALLENGES
8.4.1 LACK OF SKILLED PROFESSIONALS
8.4.2 STRINGENT REGULATIONS
9 IMPACT OF COVID-19 ON NORTH AMERICA STEM CELL MANUFACTURING MARKET
9.1 IMPACT ON PRICE
9.2 IMPACT ON DEMAND
9.3 IMPACT ON SUPPLY
9.4 KEY INITIATIVES BY MARKET PLAYER DURING COVID-19
9.5 CONCLUSION
10 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY PRODUCTS
10.1 OVERVIEW
10.2 CONSUMABLES & KITS
10.2.1 CULTURE MEDIA
10.2.2 DIFFERENTIATION KITS
10.2.3 STEM CELL ANTIBODY ARRAYS
10.2.4 IDENTIFICATION KITS
10.2.5 STEM CELL ANTIBODY PANELS
10.2.6 STEM CELL PRIMER PAIR PANELS
10.2.7 CYTOKINE PANELS FOR HEMATOPOIETIC STEM CELL EXPANSION
10.2.8 LINEAGE DEPLETION ANTIBODIES & KITS
10.2.9 OTHERS
10.3 STEM CELL LINES
10.3.1 HUMAN CELL SYSTEMS
10.3.1.1 INDUCED PLURIPOTENT EMBRYONIC STEM CELLS
10.3.1.2 MESENCHYMAL STEM CELLS
10.3.1.3 PRIMARY HUMAN CELLS
10.3.1.3.1 FIBROBLAST
10.3.1.3.2 EPITHELIAL
10.3.1.3.3 ENDOTHELIAL
10.3.1.4 HEMATOPOIETIC STEM CELLS
10.3.1.5 NEURAL STEM CELLS
10.3.1.6 CARDIAC STEM CELLS
10.3.1.7 PANCREATIC STEM CELLS
10.3.1.8 OTHERS
10.3.2 RODENT CELL SYSTEMS
10.3.2.1 PLURIPOTENT MOUSE ES CELLS
10.3.2.2 MOUSE EMBRYO CULTURE
10.3.2.3 PMEFS
10.3.2.4 MULTIPOTENT RODENT STEM CELLS
10.3.2.5 MESENCHYMAL STEM CELLS
10.3.2.6 NEURAL STEM CELLS
10.3.2.7 OTHERS
10.4 INSTRUMENTS
10.4.1 BIOREACTORS & INCUBATORS
10.4.2 CELL SORTERS
10.4.3 OTHERS
11 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 RESEARCH APPLICATIONS
11.2.1 LIFE SCIENCE RESEARCH
11.2.2 DRUG DISCOVERY AND DEVELOPMENT
11.3 CLINICAL APPLICATIONS
11.3.1 ALLOGENIC STEM CELL THERAPY
11.3.1.1 SURGERIES
11.3.1.2 MUSCULOSKELETAL DISORDERS
11.3.1.3 WOUNDS AND INJURIES
11.3.1.4 ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD)
11.3.1.5 OTHERS
11.3.2 AUTOLOGOUS STEM CELL THERAPY
11.3.2.1 WOUNDS & INJURIES
11.3.2.2 CARDIOVASCULAR DISEASES
11.3.2.3 GASTROINTESTINAL DISEASES
11.3.2.4 OTHERS
11.4 CELL & TISSUE BANKING
11.5 OTHERS
12 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY END USER
12.1 OVERVIEW
12.2 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
12.3 RESEARCH INSTITUTES AND ACADEMIC INSTITUTES
12.4 CELL BANKS & TISSUE BANKS
12.5 HOSPITALS & SURGICAL CENTERS
12.6 OTHERS
13 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT SALES
13.3 THIRD PARTY DISTRIBUTORS
14 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY REGION
14.1 NORTH AMERICA
14.1.1 U.S.
14.1.2 CANADA
14.1.3 MEXICO
15 NORTH AMERICA STEM CELL MANUFACTURING MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 THERMO FISHER SCIENTIFIC INC.
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 TAKEDA PHARMACEUTICAL COMPANY LIMITED
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 MERCK KGAA
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENTS
17.4 AMERICAN CRYOSYSTEM CORPORATION
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENTS
17.5 ANTEROGEN.CO.,LTD.
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENT
17.6 ASTELLAS PHARMA INC.
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 BD
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 COMPANY SHARE ANALYSIS
17.7.4 PRODUCT PORTFOLIO
17.7.5 RECENT DEVELOPMENT
17.8 BIO-TECHNE
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENTS
17.9 CATALENT, INC
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENTS
17.1 DAIICHI SANKYO COMPANY, LIMITED
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENT
17.11 FUJIFILM CELLULAR DYNAMICS, INC.
17.11.1 COMPANY SNAPSHOT
17.11.2 COMPANY SHARE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENTS
17.12 MESOBLAST LTD
17.12.1 COMPANY SNAPSHOT
17.12.2 REVENUE ANALYSIS
17.12.3 PRODUCT PORTFOLIO
17.12.4 RECENT DEVELOPMENT
17.13 ORGANOGENESIS INC.
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 PROMOCELL GMBH
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 REPROCELL INC.
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENTS
17.16 SARTORIUS AG
17.16.1 COMPANY SNAPSHOT
17.16.2 REVENUE ANALYSIS
17.16.3 PRODUCT PORTFOLIO
17.16.4 RECENT DEVELOPMENTS
17.17 STEMCELL TECHNOLOGIES INC.
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 VERICEL CORPORATION
17.18.1 COMPANY SNAPSHOT
17.18.2 REVENUE ANALYSIS
17.18.3 PRODUCT PORTFOLIO
17.18.4 RECENT DEVELOPMENTS
17.19 VIACYTE, INC.
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENTS
17.2 VISTAGEN THERAPEUTICS, INC.
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
표 목록
LIST OF TABLES
TABLE 1 BELOW PROVIDED ARE THE ALTERNATIVES FOR CANCER TREATMENT:
TABLE 2 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)
TABLE 3 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 4 NORTH AMERICA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA CELL & TISSUE BANKING IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA OTHERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA RESEARCH INSTITUTES AND ACADEMIC INSTITUTES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA CELL BANKS & TISSUE BANKS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA HOSPITALS & SURGICAL CENTERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA OTHERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA DIRECT SALES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA THIRD PARTY DISTRIBUTORS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 44 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 45 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 46 U.S. STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 47 U.S. CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 48 U.S. STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 49 U.S. HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 50 U.S. PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 51 U.S. RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 52 U.S. INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 53 U.S. STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 54 U.S. RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 55 U.S. CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 56 U.S. ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 U.S. AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 58 U.S. STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 59 U.S. STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 60 CANADA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 61 CANADA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 62 CANADA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 63 CANADA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 64 CANADA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 65 CANADA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 66 CANADA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 67 CANADA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 68 CANADA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 69 CANADA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 70 CANADA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 71 CANADA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 72 CANADA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 73 CANADA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 74 MEXICO STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 75 MEXICO CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 76 MEXICO STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 77 MEXICO HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 78 MEXICO PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 79 MEXICO RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 80 MEXICO INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 81 MEXICO STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 82 MEXICO RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 83 MEXICO CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 84 MEXICO ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 85 MEXICO AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 86 MEXICO STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 87 MEXICO STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
그림 목록
LIST OF FIGURES
FIGURE 1 NORTH AMERICA STEM CELL MANUFACTURING MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA STEM CELL MANUFACTURING MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA STEM CELL MANUFACTURING MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA STEM CELL MANUFACTURING MARKET : NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA STEM CELL MANUFACTURING MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA STEM CELL MANUFACTURING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA STEM CELL MANUFACTURING MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA STEM CELL MANUFACTURING MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 NORTH AMERICA STEM CELL MANUFACTURING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA STEM CELL MANUFACTURING MARKET: SEGMENTATION
FIGURE 11 INCREASING ADOPTION OF STEM CELL THERAPY IS EXPECTED TO DRIVE THE NORTH AMERICA STEM CELL MANUFACTURING MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 CONSUMABLES & KITS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA STEM CELL MANUFACTURING MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA STEM CELL MANUFACTURING MARKET
FIGURE 14 NEW CANCER CASES WORLDWIDE IN 2018
FIGURE 15 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2020
FIGURE 16 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY PRODUCTS, 2021-2028 (USD MILLION )
FIGURE 17 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY PRODUCTS, CAGR (2021-2028)
FIGURE 18 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY PRODUCTS, LIFELINE CURVE
FIGURE 19 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2020
FIGURE 20 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY APPLICATION, 2021-2028 (USD MILLION )
FIGURE 21 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 22 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 23 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY END USER, 2020
FIGURE 24 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY END USER, 2021-2028 (USD MILLION )
FIGURE 25 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY END USER, CAGR (2021-2028)
FIGURE 26 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY END USER, LIFELINE CURVE
FIGURE 27 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2020
FIGURE 28 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION )
FIGURE 29 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 30 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 31 NORTH AMERICA STEM CELL MANUFACTURING MARKET: SNAPSHOT (2020)
FIGURE 32 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY COUNTRY (2020)
FIGURE 33 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY COUNTRY (2021 & 2028)
FIGURE 34 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY COUNTRY (2020 & 2028)
FIGURE 35 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY PRODUCTS (2021-2028)
FIGURE 36 NORTH AMERICA STEM CELL MANUFACTURING MARKET: COMPANY SHARE 2020 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
